You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

MS drugs from Biogen Idec, Genzyme get recommendations from European panel

Biogen Idec has won support from a European panel for Tecfidera, a pill to treat multiple sclerosis.

A Weston company known for such MS drugs as Avonex and Tysabri, Biogen Idec said it has received a positive opinion on Tecfidera from the Committee for Medicinal Products for Human Use, which is recommending that European Union regulators approve the drug as a first-line oral treatment for adults with relapsing-remitting multiple sclerosis.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week